Retinal Disease

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

Recruiting
  • Retinitis Pigmentosa
  • +7 more
  • San Diego, California
  • +14 more
Jul 29, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)

Active, not recruiting
  • Retinitis Pigmentosa
  • +7 more
  • Dallas, Texas
  • +2 more
Apr 21, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose

Completed
  • Retinitis Pigmentosa
  • +7 more
  • QR-421a
  • Sham-procedure (dose cohort 1&2 only)
  • Boston, Massachusetts
  • +6 more
Apr 19, 2022

Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

Terminated
  • Dry Age-related Macular Degeneration
  • +4 more
  • Phoenix, Arizona
  • +28 more
Mar 22, 2022

Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)

Completed
  • Neovascular Age-related Macular Degeneration
  • +3 more
  • GEM103
  • sham + SoC
  • Phoenix, Arizona
  • +22 more
Mar 22, 2022

Natural Progression of Dry Age-related Macular Degeneration

Recruiting
  • Dry Age-related Macular Degeneration
  • +5 more
    • Phoenix, Arizona
    • +65 more
    Feb 22, 2021